Jianyou Pharmaceutical's Subsidiary Gains US FDA Approval for Vitamin B1 Injection Product
Stock News
Sep 28
Jianyou Pharmaceutical (603707.SH) has announced that its subsidiary, Hong Kong Jianyou Industrial Co., Ltd. ("Hong Kong Jianyou"), recently received an ANDA approval notice (ANDA number: 213131) from the US Food and Drug Administration ("US FDA") for Vitamin B1 Injection 200mg/2mL (100mg/mL).
The newly approved product further enriches the company's international product pipeline and strengthens its international market presence.
If subsequent launch and sales in the US market are pursued, it is expected to have a positive impact on the company's operating performance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.